WebGlobeNewswire. BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral … WebRESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present …
RBC Capital Sticks to Their Hold Rating for BioCryst (BCRX)
WebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s … WebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? eastern lift truck co. inc. upper marlboro md
2024-04-12 NDAQ:BCRX Press Release BioCryst …
WebNews. View All. March 2024 Oral Prophylaxis With Berotralstat (BCX7353) Reduces Use of Standard-of-Care On-Demand Medication in Patients With Hereditary Angioedema: … WebRESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following investor conferences: The 22 nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19 th at 8:45 a.m. ET. The BofA Securities 2024 Health … WebMar 24, 2024 · BioCryst Pharmaceuticals Inc Stock Price History. BioCryst Pharmaceuticals Inc’s price is currently down 3.95% so far this month. During the month of March, BioCryst Pharmaceuticals Inc’s stock price has reached a high of $8.99 and a low of $7.82. ... Lastly, news and media coverage as well as recent press reports about the … eastern lift truck company